AUTHOR OF THIS BLOG

DR ANTHONY MELVIN CRASTO, WORLDDRUGTRACKER
Nov 112015
 

 

Abstract Image

The safe use of diazo reagents for the preparation of a key structure in the synthesis of milnacipran analogues is described herein. Using continuous flow technology, the diazo reagent is synthesized, purified, dried, and subsequently used in semi-batch mode for an intramolecular cyclopropanation. Side products formed in the reaction are isolated and rationalized to optimize the process. Different separation techniques in flow are compared with regard to their ability to produce pure and dry diazo reagents. The studies yield a scalable process to a key intermediate in the syntheses of milnacipran and its possible substituted analogues.

 

Toward a Large-Scale Approach to Milnacipran Analogues Using Diazo Compounds in Flow Chemistry

School of Chemistry, Cardiff University, Park Place, Cardiff CF10 3AT, U.K.
Institut de Recherche Pierre Fabre, 81603 Gaillac, France
§ Pierre Fabre Médicament, Parc Industriel de la Chartreuse, 81106 Castres, France
Org. Process Res. Dev., Article ASAP
DOI: 10.1021/acs.oprd.5b00308
Publication Date (Web): October 29, 2015
Copyright © 2015 American Chemical Society
*E-mail: wirth@cf.ac.uk.

http://pubs.acs.org/doi/abs/10.1021/acs.oprd.5b00308

 

 

 

 

DRUG APPROVALS BY DR ANTHONY MELVIN CRASTO …..FOR BLOG HOME CLICK HERE

Join me on Linkedin

View Anthony Melvin Crasto Ph.D's profile on LinkedIn

Join me on Facebook FACEBOOK

Join me on twitterFollow amcrasto on Twitter
Join me on google plus Googleplus

 amcrasto@gmail.com

/////

Share

Sorry, the comment form is closed at this time.

Follow

Get every new post on this blog delivered to your Inbox.

Join other followers: